Expanding the Scope of Non-Invasive Molecular Oncology Diagnostics

The field of genomics has significantly positioned itself as a hotspot of academic scientific research and clinical medicine. Precision medicine and next-generation sequencing (NGS) are two examples of technological developments that have initiated substantial advancements in the field of oncology while also creating new opportunities for further growth.

Topics: Diagnostics Pharmaceuticals Industry Insights

$76 Billion In-Vitro Diagnostic Market Fueled by Growing Demand

In-vitro diagnostic (IVD) tests are performed on human bodily tissues or blood samples to detect diseases or disorders, or to monitor a person’s overall health to treat, prevent, or cure diseases.

Topics: Diagnostics Industry Insights

The Power of Artificial Intelligence in Cancer Diagnostics

Artificial intelligence is omnipresent. In the future, queries will be responded to by personal digital assistants, trade stocks will be monitored by robo-advisors, and driverless cars will drive people to their destinations.

Topics: Software & Enterprise Computing Diagnostics Industry Insights

Top 5 Technologies Used for Solid Tumor Testing in Laboratories

A solid lump on a person’s body is generally a cause of concern, as in some cases, it is found to be cancerous or has the probability of becoming cancerous if not treated in time.

Topics: Diagnostics Industry Insights

COVID-19 Doubled the Adoption of Molecular Diagnostics Devices and Equipment

The pandemic has accelerated the adoption of molecular diagnostics devices and equipment in the healthcare industry, highlighting the power of sequencing-based diagnostic testing in global efforts to combat the spread of the infectious diseases, and its importance in supporting recovery efforts.

Topics: Diagnostics Industry Insights

COVID-19 and Testing in the US:  Moving Forward

“Had [the US] done more testing from the very beginning and caught cases earlier,” said Dr. Nuzzo of Johns Hopkins, “we would be in a far different place.”

Topics: Diagnostics Healthcare Industry Insights

Pace of EUAs Increase as Molecular Diagnostics Vendors Submit COVID-19 Tests

Roche, Hologic, and Thermo Fisher Scientific are among the molecular diagnostic vendors that have received EUAs, or emergency use authorizations, for their tests for the novel coronavirus COVID-19.  

Topics: Diagnostics Healthcare Kalorama Information Industry Insights

Carrier Screening Market Expected to Witness Impressive Growth

Carrier screening revolves around the gene testing of individuals to understand whether a person is carrying the gene for certain genetic disorders. This test can be performed before or during the time of pregnancy to evaluate the possibility of the baby carrying any type of genetic disease.

Topics: Diagnostics Healthcare Industry Insights

5 Areas Where In Vitro Diagnostics Can Shine

In vitro diagnostic testing costs little to the healthcare system and contributes much to clinical practice.  

In vitro diagnostics (IVD) is a growing market, which is one of the reasons that so many companies need to continue to track the market using market research aids. In our latest study The Worldwide Market for In Vitro Diagnostic Tests: 12 Edition, Kalorama Information estimates the in vitro diagnostics market size at $69 billion and growing at 4%, with many sectors of the IVD market growing double that.  

Topics: Diagnostics Kalorama Information Industry Insights

U.S. Diagnostic Imaging Center Industry Worth $19 Billion

The U.S. is the largest medical imaging market globally due to the high disposable income and health insurance of consumers. More than 630 million X-rays, CT & PET scans, MRIs, ultrasounds, and mammographies are performed each year, representing an important part of the healthcare system.

Topics: Diagnostics Healthcare Industry Insights